China Health Labs & Diagnostics Ltd. Announces Conference Call
to Discuss Results of the Third Quarter Ended September 30, 2012
TSX-V: CHO
OTCQX: CHLBF
www.chinahealthlabs.com
Financial Results for the Third Quarter Ended September 30, 2012 to be Released on November 28, 2012
TORONTO,
Nov. 23, 2012 /CNW/ - China Health
Labs & Diagnostics Ltd. ("China Health" or the "Company")
(TSXV: CHO); (OTCQX: CHLBF), is pleased to announce that it will be
releasing the results of the third quarter ended September 30, 2012, on November 28, 2012, after market close, and will
be hosting an investor conference call on Thursday, November 29, 2012 at 10:00am (Eastern Time). The purpose of this
conference call will be to provide investors with an update of the
third quarter results of the Company. Representing China
Health on the conference call will be:
Mr. Shiping (Wilson)
Yao, President and Chief Executive Officer
Ms. Judyanna Chen, Chief Financial Officer
Mr. Kim Oishi, Member of the Board
of Directors
Mr. Chao Zhang, Vice President,
Finance
Following the update, a question and answer
session will be held. To participate, the dial-in
instructions are as follows:
DATE: Thursday, November 29,
2012
TIME: 10:00am, Eastern
Time
Participant Dial-In Number(s): |
|
|
|
|
|
|
North America Toll-Free Dial-In Number: |
|
|
|
|
|
|
1 (888) 231-8191 |
|
|
|
|
|
|
For Toronto and International Callers: |
|
|
|
|
|
|
1 (647) 427-7450 |
A Taped Replay will be available from
1:00 pm Eastern Time on November 29, 2012 to 11:59
pm Eastern Time on December 14,
2012.
Taped Replay Toll Free Number:
1.855.859.2056
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taped Replay Local Dial-in Numbers:
(778) 371-8506
(403) 451-9481
|
|
|
|
|
|
|
(416) 849-0833
(613) 667-0035
|
|
|
|
|
|
|
(514) 807-9274
(902) 455-3955 |
Taped Replay Password: 74573565
About China Health Labs & Diagnostics
Ltd.
China Health, operating in China as the Biochem Group, is a leading
diagnostic lab solution provider for the public healthcare industry
in China. The Company develops and
sells Biochem Group branded and third-party medical diagnostic
products and services to diagnostic facilities in China. Customers include large urban
hospitals, rural hospitals, Chinese defense and rescue operations,
the Beijing government and
third-party distributors.
The Company intends to continue to expand its
business by focusing its efforts on expanding its sales network in
three areas where it provides proprietary solutions, has limited
competition and which are supported by Chinese government policies
and budgets: BK Clinlab total lab solutions for rural hospitals and
clinics, POCT solutions for military and emergency rescue services,
and food safety solutions for large cities in China. In 2011, China Health increased
its revenues by 35% to $45.6 million,
and increased its installed base of BK Clinlab total solution
diagnostic labs ("BK Clinlabs") to from 210 locations at the start
of 2011 to 833 rural hospitals. In addition, the Company grew
revenues from its overall business in providing total lab solutions
by 99% from 2010, which increased gross margins to 44% in 2011 as
compared to 39% in 2010.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
FORWARD LOOKING INFORMATION
This press release contains forward-looking
statements and information that are based on the beliefs of
management and reflect China Health's current expectations.
When used in this press release, the words "estimate", "project",
"belief", "anticipate", "intend", "expect", "plan", "predict",
"may" or "should" and the negative of these words or such
variations thereon or comparable terminology are intended to
identify forward-looking statements and information. The
forward-looking statements and information in this press release
includes information relating to the expansion of the Company's
business through its sales network in areas where it has
proprietary products, limited competition and strong government
support. The forward-looking information is based on certain
assumptions, which could change materially in the future, including
the assumption that the Company will be able to expand its sales
network and business. Such statements and information reflect
the current view of China Health
with respect to risks and uncertainties that may cause actual
results to differ materially from those contemplated in those
forward-looking statements and information. By their nature,
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause our actual results,
performance or achievements, or other future events, to be
materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements. Such factors include, among others, the risk that the
Company may not be able to expand its business as expected through
its sales network in any of the areas in which it has proprietary
products, limited competition and strong government support.
China Health cautions that the foregoing list of material factors
is not exhaustive. When relying on China Health's forward-looking statements and
information to make decisions, investors and others should
carefully consider the foregoing factors and other uncertainties
and potential events. China Health has assumed a certain
progression, which may not be realized. It has also assumed
that the material factors referred to above will not cause such
forward-looking statements and information to differ materially
from actual results or events. However, the list of these
factors is not exhaustive and is subject to change and there can be
no assurance that such assumptions will reflect the actual outcome
of such items or factors.
THE FORWARD-LOOKING INFORMATION CONTAINED IN
THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF CHINA HEALTH AS OF THE DATE OF THIS PRESS
RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH
DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON
FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS
INFORMATION AS OF ANY OTHER DATE. WHILE CHINA HEALTH MAY ELECT TO, IT DOES NOT
UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT
AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.
SOURCE CHINA HEALTH LABS &
DIAGNOSTICS